Anzeige
Mehr »
Dienstag, 17.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
64 Leser
Artikel bewerten:
(0)

Johnson & Johnson Professional Export is Honored to be Named Winner of the Queen's Award for Enterprise - the UK's Highest Accolade for Business Success

LONDON, April 21, 2014 /PRNewswire/ --


Today, UK-based Johnson & Johnson Professional Export, a division of Johnson & Johnson Medical Ltd, is proud to celebrate the honor of winning the Queen's Award for Enterprise. The award for 'International Trade' was given in recognition of their successful domestic and international strategies which have widened access to their extensive range of medical devices and diagnostic products in emerging markets including Iran, Malta/Gibraltar and Sub-Saharan Africa.

"Our vision is to significantly increase the number of healthcare professionals and ultimately patients who benefit from our advanced medical devices and diagnostic products. By achieving consistent growth we have been able to increase investment in this region, offering the best possible training for healthcare professionals while building valuable partnerships with local organizations, businesses and customers in both the UK and Emerging Markets," said Johnson & Johnson Professional Export Managing Director, Ian Walker.

Johnson & Johnson Professional Export prides itself on being a dynamic, customer-driven organization that operates through 45 distributors in 43 countries. Receiving a prestigious Queen's Award not only acknowledges the company's continued commitment to improving healthcare through Corporate Social Responsibility initiatives in Africa, but its significant investment in training and education.

For example, Johnson & Johnson offers unique local education programs for surgeons in Sub-Saharan Africa, establishing two regional training centres in Ghana and Kenya in partnership with Korle Bu Hospital in Accra and Nairobi University Medical School. Through these facilities, Johnson & Johnson has been able to train in excess of 1,200 healthcare professionals across a range of surgical procedures, enabling expanded access to healthcare for patients in parts of the region that have historically been more challenging to reach.

EMEA Company Group Chairman Sabine Dandiguian said, "Inspired by Our Credo, Johnson & Johnson is working to ensure emerging markets such as Sub-SaharanAfricagain access to the best possible healthcare. We are proud that Johnson & Johnson Professional Export has been awarded such a prestigious accolade to recognize their business and community impact in this region."

As a winner of the Queen's Award for Enterprise, Johnson & Johnson Professional Export will be invited to attend a special reception at Buckingham Palace later this year.

Johnson & Johnson Professional Export, a division of Johnson & Johnson Medical Ltd is based at Kirkton Campus, Livingston, Scotland.

Notes to Editors

About Johnson & Johnson

Caring for the world one person at a time inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 128,000 employees at more than 275 Johnson & Johnson operating companies work with partners in healthcare to touch the lives of over a billion people throughout the world every day. For more information please visit http://www.jnj.com.

About the Queen's Award

Approximately 160 Queen's Awards have been announced this year for outstanding business achievement in the fields of International Trade, Innovation and Sustainable Development.

The awards are made annually by HM The Queen, and are only given for the highest levels of excellence demonstrated in each category. To find out more visit http://www.queendsawards.org.uk.

© 2014 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.